Fluid Status of ESRD Patients Undergoing Dialysis

NCT07217470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2025-12-02

No results posted yet for this study

Summary

The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.

Conditions

  • ESRD (End Stage Renal Disease)

Sponsors & Collaborators

  • HemoCept Inc.

    lead INDUSTRY

Principal Investigators

  • Jusmin Patel, MD · Sierra Nevada Specialty Care

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-18
Primary Completion
2025-11-20
Completion
2025-11-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07217470 on ClinicalTrials.gov